Wrap up: Proton pump inhibits could help fight cancer and immune disorders in canine patients, and other news

Prostock-studio/stock.adobe.com

Good morning dvm360 readers! Today is the LAST day to nominate your veterinary hero! Each year, dvm360 honors veterinary professionals through a peer nominated awards program. The Veterinary Heroes award is presented to professionals in all walks of life within veterinary medicine from client service representative to emergency medicine. To learn more about the awards and submit your veterinary hero today, check out the official Veterinary Heroes Awards website.

Here are the top headlines this week on dvm360.com:

• Researchers at Texas A&M School of Veterinary Medicine and Biomedical Sciences shared their recent research investigating the use of proton pump inhibitors as an effective way to help assist chemotherapy in fighting cancer and immune disorders in canines.
• Embrace Pet Insurance announced the results of a survey it conducted with over 12,000 pet insured patients to get a better understand of veterinary care and pet wellness trends from a pet owner point of view.
• On this week’s episode of The Vet Blast Podcast, Amy Thomson, DVM, DAVDC, sat down with host Adam Christman, DVM, MBA, to discuss how to successfully partner with a dental specialist, when to refer, and more.
• ImpriMed, a precision medicine startup, launched an artificial service to deliver personalized anticancer drug response predictions for dogs diagnosed with lymphoma or leukemia.
• (OKV-119; Vivani Medical), a long-term drug delivery system typically used for chronic weight management in humans, is now being tested for use in cats to support feline obesity and diabetes management.
• Audley Travel, a tour operator based in the United Kingdom, analyzed Google search data within the United Kingdom to unveil the 10 endemic wildlife species travels want to encounter in Australia, and top of the list is the quokka.
• And more!